Atea Pharmaceuticals, Inc. vs GILEAD SCIENCES, INC.,

Notice: refund approved

Request for Redund

EXPUNGED

DECISION Denying Institution of Post-Grant Review 35 U.S.C. § 324(a)

Patent Owner's Preliminary Response

Patent Owner's Exhibit List

“FDA Approves Gilead's Hepatitis C Drug”, Wall Street Journal (December 6, 2013)

“F.D.A. Approves Pill to Treat Hepatitis C”, NYTimes (December 7, 2013)

“Gilead Remains Steadfast in Support for Hepatitis C Elimination Efforts”, Gilead Press Release (April 3, 2023)

“U.S. Food and Drug Administration Approves Gilead’s Sovaldi™ (Sofosbuvir) for the Treatment of Chronic Hepatitis C”, Gilead Press Release (December 6, 2013)

Young et al., “Hepatitis C Protease and Polymerase Inhibitors in Development”, AIDS PATIENT CARE and STDs, Vol. 22, No. 6 (2008)

Clark et al., “Design, Synthesis, and Antiviral Activity of 2′-Deoxy-2′-fluoro-2′-C-methylcytidine, a Potent Inhibitor of Hepatitis C Virus Replication”, J. Med. Chem. 2005, 48, 5504-5508

U.S. Patent No. 7,429,572

U.S. Patent No. 8,815,830

U.S. Patent No. 8,735,372

U.S. Patent No. 8,906,880

U.S. Patent No. 8,957,046

Part 1 - Partial file history for U.S. Patent No. 7,964,580 (pp. 1-408)

Part 2 - Partial file history for U.S. Patent No. 7,964,580 (pp. 409-818)

Part 3 - Partial file history for U.S. Patent No. 7,964,580 (pp. 819-1050)

Part 4 - Partial file history for U.S. Patent No. 7,964,580 (pp. 1051-1326)

Part 1 - Partial file history for U.S. Patent No. 8,334,270 (pp. 1-434)

Part 2 - Partial file history for U.S. Patent No. 8,334,270 (pp. 435-862)

Part 3 - Partial file history for U.S. Patent No. 8,334,270 (pp. 863-1152)

Part 1 - Partial file history for U.S. Patent No. 8,580,765 (pp. 1-432)

Part 2 - Partial file history for U.S. Patent No. 8,580,765 (pp. 433-848)

Part 3 - Partial file history for U.S. Patent No. 8,580,765 (pp. 849-1288)

Part 4 - Partial file history for U.S. Patent No. 8,580,765 (pp. 1289-1706)

Part 5 - Partial file history for U.S. Patent No. 8,580,765 (pp. 1707-2156)

Part 6 - Partial file history for U.S. Patent No. 8,580,765 (pp. 2157-2561)

Part 7 - Partial file history for U.S. Patent No. 8,580,765 (pp. 2562-2915)

Part 1 - Partial file history for U.S. Patent No. 9,085,573 (pp. 1-435)

Part 2 - Partial file history for U.S. Patent No. 9,085,573 (pp. 436-862)

Part 3 - Partial file history for U.S. Patent No. 9,085,573 (pp. 863-1312)

Part 4 - Partial file history for U.S. Patent No. 9,085,573 (pp. 1313-1712)

Part 5 - Partial file history for U.S. Patent No. 9,085,573 (pp. 1713-2152)

Part 6 - Partial file history for U.S. Patent No. 9,085,573 (pp. 2153-2574)

Part 7 - Partial file history for U.S. Patent No. 9,085,573 (pp. 2575-2660)

Part 1 - Partial file history for U.S. Patent No. 9,585,906 (pp. 1-435)

Part 2 - Partial file history for U.S. Patent No. 9,585,906 (pp. 436-871)

Part 3 - Partial file history for U.S. Patent No. 9,585,906 (pp. 872-1082)

Part 1 - Partial file history for U.S. Patent No. 10,183,037 (pp. 1-225)

Part 2 - Partial file history for U.S. Patent No. 10,183,037 (pp. 226-460)

Part 3 - Partial file history for U.S. Patent No. 10,183,037 (pp. 461-697)

Part 4 - Partial file history for U.S. Patent No. 10,183,037 (pp. 698-890)

Part 5 - Partial file history for U.S. Patent No. 10,183,037 (pp. 891-992)

Part 1 - File history for U.S. Patent App. No. 16/169,878 (pp. 1-184)

Part 2 - File history for U.S. Patent App. No. 16/169,878 (pp. 185-418)

Part 3 - File history for U.S. Patent App. No. 16/169,878 (pp. 419-654)

Part 4 - File history for U.S. Patent App. No. 16/169,878 (pp. 655-811)

Part 1 - File history for U.S. Patent App. No. 16/516,192 (pp. 1-284)

Part 2 - File history for U.S. Patent App. No. 16/516,192 (pp. 285-587)

Part 3 - File history for U.S. Patent App. No. 16/516,192 (pp. 588-776)

Part 1 - File history for U.S. Patent App. No. 16/817,318 (pp. 1-226)

Part 2 - File history for U.S. Patent App. No. 16/817,318 (pp. 227-456)

Part 3 - File history for U.S. Patent App. No. 16/817,318 (pp. 457-684)

Part 4 - File history for U.S. Patent App. No. 16/817,318 (pp. 685-792)

Part 1 - Partial file history for U.S. Patent No. 8,735,372 (pp. 1-288)

Part 2 - Partial file history for U.S. Patent No. 8,735,372 (pp. 289-590)

Part 3 - Partial file history for U.S. Patent No. 8,735,372 (pp. 591-830)

Part 4 - Partial file history for U.S. Patent No. 8,735,372 (pp. 831-1082)

Part 5 - Partial file history for U.S. Patent No. 8,735,372 (pp. 1083-1382)

Part 6 - Partial file history for U.S. Patent No. 8,735,372 (pp. 1383-1683)

Part 7 - Partial file history for U.S. Patent No. 8,735,372 (pp. 1684-1970)

Part 8 - Partial file history for U.S. Patent No. 8,735,372 (pp. 1971-2245)

Part 9 - Partial file history for U.S. Patent No. 8,735,372 (pp. 2246-2481)

Part 1 - Partial file history for U.S. Patent No. 8,906,880 (pp. 1-242)

Part 2 - Partial file history for U.S. Patent No. 8,906,880 (pp. 243-467)

Part 3 - Partial file history for U.S. Patent No. 8,906,880 (pp. 468-700)

Part 4 - Partial file history for U.S. Patent No. 8,906,880 (pp. 701-910)

Part 5 - Partial file history for U.S. Patent No. 8,906,880 (pp. 911-1054)

Part 1 - Partial file history for U.S. Patent No. 8,957,046 (pp. 1-215)

Part 2 - Partial file history for U.S. Patent No. 8,957,046 (pp. 216-438)

Part 3 - Partial file history for U.S. Patent No. 8,957,046 (pp. 439-670)

Part 4 - Partial file history for U.S. Patent No. 8,957,046 (pp. 671-877)

Part 5 - Partial file history for U.S. Patent No. 8,957,046 (pp. 878-1170)

Part 6 - Partial file history for U.S. Patent No. 8,957,046 (pp. 1171-1456)

Part 7 - Partial file history for U.S. Patent No. 8,957,046 (pp. 1457-1737)

Part 8 - Partial file history for U.S. Patent No. 8,957,046 (pp. 1738-1996)

Part 9 - Partial file history for U.S. Patent No. 8,957,046 (pp. 1997-2019)

Gilead Sciences v. Nucana PLC [2023] EWHC 611 (Pat); Case No: HP-2021-000007 (Approved Judgment)

“Hepatitis C replicon system and drug development”, 2016 Lasker-DeBakey Clinical Medical Research Award

Part 1 - File history for U.S. Patent No. 11,642,361 (pp. 1-222)

Part 2 - File history for U.S. Patent No. 11,642,361 (pp. 223-451)

Part 3 - File history for U.S. Patent No. 11,642,361 (pp. 452-676)

Part 4 - File history for U.S. Patent No. 11,642,361 (pp. 677-900)

Part 5 - File history for U.S. Patent No. 11,642,361 (pp. 901-1133)

Part 6 - File history for U.S. Patent No. 11,642,361 (pp. 1134-1366)

Part 7 - File history for U.S. Patent No. 11,642,361 (pp. 1367-1665)

Part 8 - File history for U.S. Patent No. 11,642,361 (pp. 1666-1964)

Part 9 - File history for U.S. Patent No. 11,642,361 (pp. 1965-2250)

Part 10 - File history for U.S. Patent No. 11,642,361 (pp. 2251-2552)

Part 11 - File history for U.S. Patent No. 11,642,361 (pp. 2553-2741)

File history excerpts of Utility Patent Application Transmittal Sheets for Idenix Pharmaceuticals, Inc.’s U.S. Patent Nos. 6,914,054; 7,608,597; and 7,608,600

Atea Pharmaceuticals Founder, Chairman & CEO: Jean-Pierre Sommadossi

U.S. Patent No. 6,914,054

U.S. Patent No. 7,608,597

Part 1 - U.S. Patent No. 7,608,600 (pp. 1-348)

Part 2 - U.S. Patent No. 7,608,600 (pp. 349-722)

Part 3 - U.S. Patent No. 7,608,600 (pp. 723-1104)

Part 4 - U.S. Patent No. 7,608,600 (pp. 1105-1129)

Jinfa Du LinkedIn Profile

Dhanapalan Nagarathnam LinkedIn Profile

Michael Sofia LinkedIn Profile

Peiyuan Wang LinkedIn Profile

Notice : Power of Attorney

Notice : Mandatory Notice

Notice: Notice filing date accorded

Notice : Power of Attorney - Petitioner

EX. 1001 - US 11642361

Ex. 1002 - Excerpted File History of US 11642361

Ex. 1003 - USSN 60/909315

Ex. 1004 - USSN 60/982309

Ex. 1005 - US 7964580

Ex. 1006 - US 8334270

Ex. 1007 - US 8580765

Ex. 1008 - US 9085573

Ex. 1009 - US 9585906

Ex. 1010 - US 10183037

Ex. 1011 - USSN 16/169,878

Ex. 1012 - USSN 16/516,192

Ex. 1013 - USSN 16/817,318

Ex. 1014 - USSN 17/077,267

Ex. 1016 - USSN 62/129,319

Ex. 1017 - USSN 62/253,958

Ex. 1018 - USSN. 62/276,597

Ex. 1019 - USSN 15/063,461

Ex. 1020 - US 2016/0257706

Ex. 1021 - US 9828410

Ex. 1022 - IPR2017-01712 - Gilead Sciences, Inc. Petition (Paper 1)

Ex. 1023 - IPR2017-01712 - Gilead Petitioner's Reply (Paper 57)

Ex. 1024 - IPR2017-01712 - Final Written Decision (Paper 67)

Ex. 1025 - IPR2017-01712 - Gilead Ex. 1011 - Marquez Declaration

Ex. 1026 - Univ. of Minn. v. Gilead, 61 F.4th 1350 (Fed. Cir. 2023)

Ex. 1027 - Crowther et al.

Ex. 1028 - US 7429572

Ex. 1029 - EP 2955190B1

Ex. 1030 - Gilead's Request to Institute Revocation EP2955190B1

Ex. 1031 - Gilead's Particulars of Claim to Invalidate UK 2955190

Ex. 1032 - First Expert Report of Micklefield on Behalf of Gilead

Ex. 1033 - Seppelt

Ex. 1034 - Willis

Ex. 1035 - Chebrkov et al.

Ex. 1036 - Expert Report of Geert-Jan Boons on Behalf of Gilead

Ex. 1037 - Second Declaration of Geert-Jan Boons on Behalf of Gilead

Ex. 1038 - EPO Appeal - Statement of Grounds of Appeal on Behalf of Gilead

Ex. 1039 - Second Expert Report of Micklefield on Behalf of Gilead

Ex. 1040 - Expert Report of Prof. Götte on Behalf of Gilead

Ex. 1041 - Second Expert Report of Prof. Götte on Behalf of Gilead

Ex. 1042 - Perkins

Ex. 1043 - US 2005/0009737

Ex. 1044 - US 2006/0199783

Ex. 1045 - US 2006/0122146

Ex. 1046 - US 2007/0197463

Ex. 1015 - Declaration of Alexander M. Klibanov, Ph.D.

Petition : as filed

Ex. 1047 - Declaration of Thorsten-Bausch